Researchers have discovered that cholangiocarcinoma (CCA), a form of liver cancer also known as bile duct cancer, consists of several molecular subtypes with distinct potential therapies and prognoses.
Dec 13, 2017
0
5
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which ...
Oct 16, 2017
0
1
An international multidisciplinary team of researchers from a number of institutions, including Baylor College of Medicine, Brigham and Women's Hospital, the University of Texas MD Anderson Cancer Center, British Columbia ...
Oct 6, 2017
0
15
Using newly developed software, researchers have shown that genes and molecular processes in breast cancer tumor cells are tightly linked to genes and processes in blood cells, including immune system cells. The findings ...
Sep 28, 2017
0
3
(HealthDay)—There is considerable interpersonal and intrapersonal agreement on the presence of basal cell carcinoma (BCC) on Mohs slides, according to a study published online April 1 in the British Journal of Dermatology.
Apr 7, 2016
0
1
Cutaneous melanoma, the most deadly form of skin cancer, is now believed to be divided into four distinct genomic subtypes, say researchers at The University of Texas MD Anderson Cancer Center, a finding that could prove ...
Jun 18, 2015
0
1157
In the previous few years, several breakthrough treatments have become available for key subtypes of lung cancer. Patients who may benefit from these treatments can be pre-identified by looking for defined genetic abnormalities ...
Aug 22, 2014
0
0
Molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found. Results of the research were presented today at the ...
Jun 1, 2014
0
0
Results of EORTC trial 10994 appearing in the Annals of Oncology show that pathological complete response after neoadjuvant chemotherapy is an independent predictive factor of favorable clinical outcomes in all molecular ...
Apr 2, 2014
0
0
Women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease more than 10 years after diagnosis, according to a Kaiser Permanente study published in the journal Cancer ...
Sep 18, 2012
0
0
